Indietro

Abbott Laboratories

Ticker: ABT ISIN: US0028241000
Aggiungi al portafoglio Analisi del portafoglio in 2min
Stock Large-cap Dividend payer Trading above 200-day average
Capitalizzazione
154,15 Mld $
P/E
24,79
Forward P/E
16,53
Profit margin
13,90%
Revenue growth QoQ
7,80%
Div. yield
2,69%
Beta
0,62
116,13 $ -0,46%
Prezzo al 2026-08-25 · NYSE

Performance per periodo

Rendimenti cumulativi
1 Month +11,14%
6 Months +2,55%
1 Year -9,71%
5 Years +0,54% p.a.+2,73%
10 Years +12,49% p.a.+224,14%
Since inception +9,55% p.a.+874,83%
Rendimenti per anno
YTD -5,59%
2025 +12,87%
2024 +4,82%
2023 +2,26%
2022 -20,68%
2021 +30,53%

Key stats

Market cap
154,15 Mld
P/E
24,79
Dividend yield
2,69%
Beta
0,62
52-week range
81.97 - 136.28
50-day MA
90,43
200-day MA
113,85
Section 1

Business overview

Company profile data from fundamentals.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 12,33%
ROA 5,59%
Profit margin 13,90%
Operating margin 13,47%
PEG ratio 1,34
Revenue/share TTM 25,91
Revenue TTM 45,13 Mld
EBITDA 11,74 Mld
Gross profit TTM 25,50 Mld
Beta 0,62

Valuation

Trailing P/E 24,79
Forward P/E 16,53
P/B 3,03
P/S 3,42
EV/EBITDA 15,60
EV/Revenue 4,09

ESG Scores

Total ESG 32,4
Environment 4,0
Social 20,7
Governance 13,2
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 5,48
Quarterly earnings growth -19,70%
Revenue TTM 45,13 Mld
Reported quarters 129
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 2,69%
Forward annual div. yield 1,75%
Dividend per share 2,4400
Payout ratio 53,70%
Ex-dividend date 2025-07-15
Next dividend date 2026-08-17
Split factor 10000:4798
Last split date 2013-01-02
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 142,48 $
Analyst rating 4.1071

Ownership & short interest

Shares outstanding 1,74 Mld
Shares float 1,73 Mld
Institutional ownership 80,78%
Insider ownership 54,30%
Short ratio 1,73
Short % of float 1,41%

Details

Instrument metadata and source update timestamps.

Symbol ABT
Name Abbott Laboratories
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US0028241000
Country USA
Code + exchange ABT.NYSE
Last price date 2026-06-17
Fundamentals updated 2026-06-18

Le informazioni fornite su questa piattaforma hanno solo scopo informativo e non devono essere considerate consulenza finanziaria o di investimento. Insightfolio non fornisce consulenza d'investimento, raccomandazioni personalizzate o indicazioni relative all'acquisto, alla detenzione o alla vendita di strumenti finanziari. Gli strumenti e i contenuti sono destinati esclusivamente a finalita educative e non sono adattati alle circostanze individuali, alle esigenze finanziarie o agli obiettivi personali.

Insightfolio non si assume alcuna responsabilita per l'accuratezza, la completezza o l'affidabilita delle informazioni presentate. Gli utenti sono gli unici responsabili della verifica delle informazioni e dell'assunzione di decisioni indipendenti basate sulla propria ricerca e su un'attenta valutazione. L'uso della piattaforma non deve sostituire la consulenza di professionisti finanziari qualificati.

Gli investimenti comportano rischi. Gli utenti devono essere consapevoli che il valore degli investimenti puo variare e che i rendimenti passati non sono indicativi di risultati futuri. Le decisioni di investimento devono basarsi sugli obiettivi finanziari personali, sulla tolleranza al rischio e su una valutazione indipendente delle informazioni rilevanti.

Insightfolio non approva ne garantisce l'idoneita di alcun prodotto finanziario, titolo o strategia specifica. Eventuali proiezioni, previsioni o scenari ipotetici presentati sulla piattaforma hanno solo scopo illustrativo e non costituiscono garanzia di risultati futuri.

Accedendo ai servizi, alle informazioni o ai contenuti offerti da Insightfolio, gli utenti riconoscono e accettano i presenti termini di esclusione di responsabilita. Se non accetti questi termini, ti invitiamo a non utilizzare la piattaforma.

Instrument logos provided by Elbstream.